minaprine has been researched along with Dementia in 1 studies
minaprine: Agr 1240 refers to di-HCl; short-acting type A MAO inhibitor (MAOI) of mild potency; structure
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passeri, M | 1 |
| Cucinotta, D | 1 |
| de Mello, M | 1 |
| Storchi, G | 1 |
| Roncucci, R | 1 |
| Bizière, K | 1 |
1 trial available for minaprine and Dementia
| Article | Year |
|---|---|
Minaprine for senile dementia.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Humans; Middle Aged; Pyridazines | 1985 |